Pharmacokinetics of Antiepileptic Drugs in Pediatric Patients
Summary
Pharmacokinetic processes—absorption, distribution, metabolism and excretion—exhibit marked variability in paediatric populations, driven by developmental changes in organ function, enzyme activity and body composition. In the context of antiepileptic therapy, these age-dependent differences complicate the attainment of stable plasma concentrations required to suppress seizure activity while minimising adverse effects. First-generation agents such as carbamazepine, phenytoin and valproate are characterised by nonlinear metabolism and narrow therapeutic windows, making dose individualisation and therapeutic drug monitoring essential. Newer compounds including levetiracetam and lamotrigine offer more predictable kinetics but still require careful titration in infants and children with rapidly evolving renal and hepatic clearance. Global research efforts have focused on population pharmacokinetic modelling, novel sampling techniques (for example, sparse sampling and dried blood-spot analysis) and model-informed dosing to reduce invasiveness and improve precision in paediatric cohorts. These advances carry significant clinical implications, offering pathways to safer, more effective seizure management across all developmental stages.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Pharmacokinetics of Antiepileptic Drugs in Pediatric Patients publication trend
The graph below shows the total number of articles in pharmacokinetics of antiepileptic drugs in pediatric patients across all publications each year (not limited to Nature Index journals).
Technical terms
Pharmacokinetics: Study of how a drug is absorbed, distributed, metabolised and excreted.
Therapeutic drug monitoring: Measurement of drug concentrations to guide dosing and ensure efficacy and safety.
Bioavailability: Proportion of an administered dose that reaches the systemic circulation in an active form.
Trough concentration: Lowest drug concentration in the bloodstream, measured just before the next dose.
Therapeutic range: Blood concentration interval within which a drug is likely to be effective without causing toxicity.
Population pharmacokinetic modelling: Use of mathematical models to predict drug concentration–time profiles in different patient groups.
References
- Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study. Journal of Clinical Medicine (2021).
- Interaction of Carbamazepine with Herbs, Dietary Supplements, and Food: A Systematic Review. Evidence-based Complementary and Alternative Medicine (2013).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.